CVS Health (CVS) Stock Price, News & Analysis

Company Overview

CVS Health Corporation is a diversified health services company that operates one of the largest pharmacy chains in the United States. Through its retail pharmacies, specialty pharmacy services and pharmacy benefit management division, the company provides prescription medications, over-the-counter products and clinical services to millions of customers. In addition, CVS Health offers insurance products and services through its Aetna business, enabling integrated care solutions that span medication management, wellness programs and care coordination.

The company traces its origins to 1963 when it was founded as Consumer Value Stores in Lowell, Massachusetts. Over the decades, CVS expanded its footprint through organic growth and strategic acquisitions, including the 2007 acquisition of Caremark Rx and the 2018 acquisition of Aetna. Headquartered in Woonsocket, Rhode Island, CVS Health today serves customers in all 50 states, the District of Columbia and Puerto Rico. Its network encompasses approximately 9,900 retail locations, more than 1,100 walk-in clinics and a nationwide home delivery pharmacy business.

Core offerings include retail pharmacy, specialty pharmacy and pharmacy benefit management services through CVS Caremark. The company’s retail pharmacies provide prescription fulfillment, immunizations and health screenings, while MinuteClinic walk-in medical clinics offer basic primary care and chronic disease management. Through its health insurance segment, CVS Health delivers medical, dental, pharmacy and behavioral health plans for individuals, employers and government programs. Digital tools such as the CVS Pharmacy mobile app and telehealth services further support remote care access and medication adherence initiatives.

Under the leadership of President and Chief Executive Officer Karen S. Lynch, CVS Health is focused on advancing an integrated health care model that emphasizes preventive care, value-based reimbursement and expanded consumer access to services. The company continues to explore strategic partnerships and investments aimed at lowering health care costs, improving patient outcomes and strengthening its omnichannel capabilities across retail, clinical and digital channels.

Key Stats

• Today's Range: $64.21 to $65.24
• 50-Day Range: $60.03 to $69.56
• 52-Week Range: $43.56 to $72.51
• Volume: 7.02 million shs
• Average Volume: 10.80 million shs
• Market Capitalization: $81.88 billion
• P/E Ratio: 15.45
• Dividend Yield: 4.11%
• Price Target: $75.38
• Consensus Rating: Moderate Buy

CVS Health Stock Analysis - MarketRank™

CVS Health scored higher than 100% of companies evaluated by MarketBeat, and ranked 6th out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

CVS Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.95, and is based on 17 buy ratings, 2 hold ratings, and no sell ratings.

Amount of Analyst Coverage

CVS Health has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 3.8 / 5
• Proj. Earnings Growth: 14.94%

Earnings Growth

Earnings for CVS Health are expected to grow by 14.94% in the coming year, from $5.89 to $6.77 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of CVS Health is 15.45, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.90.

Price to Earnings Ratio vs. Sector

The P/E ratio of CVS Health is 15.45, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 27.96.

Price to Earnings Growth Ratio

CVS Health has a PEG Ratio of 0.94. PEG Ratios below 1 indicate that a company could be undervalued.

Price to Book Value per Share Ratio

CVS Health has a P/B Ratio of 1.08. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.27% of the float of CVS Health has been sold short.

Short Interest Ratio / Days to Cover

CVS Health has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in CVS Health has recently decreased by 14.38%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 3.3 / 5
• Dividend Strength: Strong

Dividend Leadership

CVS Health is a leading dividend payer. It pays a dividend yield of 4.05%, putting its dividend yield in the top 25% of dividend-paying stocks.

Dividend Growth

CVS Health has only been increasing its dividend for 4 years.

Dividend Coverage

The dividend payout ratio of CVS Health is 63.48%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, CVS Health will have a dividend payout ratio of 39.29% next year. This indicates that CVS Health will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: 3.9 / 5
• Environmental Score: -1.25

Percentage of Shares Shorted

1.27% of the float of CVS Health has been sold short.

Short Interest Ratio / Days to Cover

CVS Health has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in CVS Health has recently decreased by 14.38%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 3.4 / 5
• News Sentiment: 1.13

News Sentiment

CVS Health has a news sentiment score of 1.13. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.00 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 50 news articles for CVS Health this week, compared to 41 articles on an average week.

Search Interest

54 people have searched for CVS on MarketBeat in the last 30 days. This is an increase of 8% compared to the previous 30 days.

MarketBeat Follows

Only 23 people have added CVS Health to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 3.3 / 5
• Insider Trading: Acquiring Shares

Insider Buying vs. Insider Selling

In the past three months, CVS Health insiders have bought more of their company's stock than they have sold. Specifically, they have bought $100,009.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

Only 1.22% of the stock of CVS Health is held by insiders.

Percentage Held by Institutions

80.66% of the stock of CVS Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

CVS Stock Analysis - Frequently Asked Questions

How have CVS shares performed this year?

CVS Health's stock was trading at $44.89 at the start of the year. Since then, CVS stock has increased by 44.2% and is now trading at $64.73.

How were CVS Health's earnings last quarter?

CVS Health Corporation (NYSE:CVS) released its earnings results on Thursday, May, 1st. The pharmacy operator reported $2.25 EPS for the quarter, beating analysts' consensus estimates of $1.62 by $0.63. The company's quarterly revenue was up 7.0% on a year-over-year basis.
Read the conference call transcript.

Does CVS Health have any subsidiaries?

The following companies are subsidiaries of CVS Health: IlliniCare Health, EntrustRX, Aetna, TargetPharmacy, Omnicare, Navarro Discount Pharmacy, Coram Specialty Infusion, and others.

Who are CVS Health's major shareholders?

Top institutional investors of CVS Health include Swedbank AB (0.18%), Kingstone Capital Partners Texas LLC (0.17%), Assenagon Asset Management S.A. (0.14%) and Canoe Financial LP (0.13%). Insiders that own company stock include Thomas M Moriarty, Karen S Lynch, Alan Lotvin, Prem S Shah, Michael F Mahoney, Edward J Ludwig, Guy P Sansone, Guy P Sansone and James David Clark.
View institutional ownership trends.

How do I buy shares of CVS Health?

Shares of CVS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of CVS Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that CVS Health investors own include NVIDIA (NVDA), Meta Platforms (META), Symbotic (SYM), JPMorgan Nasdaq Equity Premium Income ETF (JEPQ), Advanced Micro Devices (AMD), Chevron (CVX) and Tesla (TSLA).

Company Calendar

• Record date for 5/1 Dividend: 4/22/2025
• Ex-Dividend for 5/1 Dividend: 4/22/2025
• Last Earnings: 5/01/2025
• Dividend Payable: 5/01/2025
• Today: 7/11/2025
• Record date for 8/1 Dividend: 7/22/2025
• Ex-Dividend for 8/1 Dividend: 7/22/2025
• Next Earnings (Estimated): 7/31/2025
• Dividend Payable: 8/01/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Medical Services
• Sub-Industry: Drug Retail
• Current Symbol: NYSE:CVS
• CIK: 64803
• Web: www.cvshealth.com
• Phone: (401) 765-1500
• Fax: 401-762-2137
• Employees: 300,000
• Year Founded: 1963

Price Target and Rating

• Average Price Target for CVS Health: $75.38
• High Price Target: $84.00
• Low Price Target: $62.00
• Potential Upside/Downside: +16.4%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.95
• Research Coverage: 20 Analysts

Profitability

• EPS (Trailing Twelve Months): $4.19
• Trailing P/E Ratio: 15.45
• Forward P/E Ratio: 10.99
• P/E Growth: 0.94
• Net Income: $4.61 billion
• Net Margins: 1.39%
• Pretax Margin: 1.90%
• Return on Equity: 10.59%
• Return on Assets: 3.17%

Debt

• Debt-to-Equity Ratio: 0.77
• Current Ratio: 0.82
• Quick Ratio: 0.63

Sales & Book Value

• Annual Sales: $372.81 billion
• Price / Sales: 0.22
• Cash Flow: $8.97 per share
• Price / Cash Flow: 7.22
• Book Value: $60.18 per share
• Price / Book: 1.08

Miscellaneous

• Outstanding Shares: 1,265,020,000
• Free Float: 1,249,586,000
• Market Cap: $81.88 billion
• Optionable: Optionable
• Beta: 0.57